Exchange Traded Concepts’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Exchange Traded Concepts’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,917	Closed	-$332K	–	1320
2022 Q4	$332K	Sell	2,917 -174	-6%	-$14.5K	0.01%	668
2022 Q3	$191K	Buy	+3,091	New	+$216K	0.01%	688
2022 Q1	–	Sell	-4,863	Closed	-$524K	–	1436
2021 Q4	$524K	Buy	+4,863	New	+$531K	0.01%	668
2021 Q3	–	Sell	-8,598	Closed	-$805K	–	1301
2021 Q2	$805K	Buy	8,598 +8,328	+3,084%	+$766K	0.03%	369
2021 Q1	$25K	Sell	270 -1,086	-80%	-$91.6K	﹤0.01%	871
2020 Q4	$99K	Buy	1,356 +1,215	+862%	+$90.3K	﹤0.01%	668
2020 Q3	$11K	Buy	141 +102	+262%	+$7.02K	﹤0.01%	686
2020 Q2	$2K	Buy	+39	New	+$1.67K	﹤0.01%	738

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Exchange Traded Concepts's HZNP Position: Q1 2023 in Review

Exchange Traded Concepts sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 2,917 shares — an estimated $332K sold.

Exchange Traded Concepts first reported a position in HZNP in Q2 2020 and held it in 8 quarters. The position peaked at $805K in Q2 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Exchange Traded Concepts reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Exchange Traded Concepts sold 2,917 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $332K.
Exchange Traded Concepts first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 8 quarters.
Exchange Traded Concepts's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $805K in Q2 2021.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Exchange Traded Concepts's 13F filing for Q1 2023, filed 12 Apr 2023.